NEW FOR 2026: Phase 3 Trial Updates In March 2026 , Eli Lilly released landmark topline results from the TRANSCEND-T2D-1 Phase 3 clinical trial
These medications are not indicated for type 1 diabetes or diabetic ketoacidosis (DKA)
All states allow physicians to administer medication to their patientsmeaning to inject or give a dose to the patient at the practiceand usually allow a limited ability to dispense an amount of medication for them to use at home
The Use of Alternative Brain-Boosting Supplements Beyond peptides, numerous other supplements are explored for their brain boosting potential
Important: GHK-Cu is a research compound and is not FDA-approved
Weight Loss Benefits Enhance emotional health, mental clarity, and improved mood Lower blood pressure Reduce triglycerides Lower risk of heart disease Improve insulin resistance Reduce your risk for multiple cancers Reduce the need for prescription drugs Increase your energy levels Enhance your immune system With the latest scientific research guiding us and approval from our team of doctors, our programs are developed to ensure that you reach optimal results in a safe and effective way